Lexeo Therapeutics, Inc.
LXEO
$4.84
-$0.12-2.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 211.70M | 193.04M | 181.77M | 122.76M | 132.89M |
| Total Receivables | 1.30M | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.91M | 7.82M | 6.63M | 5.03M | 7.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 217.91M | 200.86M | 188.39M | 127.79M | 140.06M |
|
|
|||||
| Total Current Assets | 217.91M | 200.86M | 188.39M | 127.79M | 140.06M |
| Net Property, Plant & Equipment | 7.88M | 8.35M | 8.86M | 9.41M | 9.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M |
| Total Assets | 254.90M | 250.36M | 268.69M | 143.84M | 176.07M |
|
|
|||||
| Total Accounts Payable | 4.18M | 3.34M | 4.86M | 4.66M | 20.03M |
| Total Accrued Expenses | 8.58M | 8.06M | 9.20M | 9.69M | 8.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.67M | 2.70M | 2.68M | 2.72M | 2.66M |
| Total Finance Division Other Current Liabilities | 266.00K | 103.00K | 73.00K | 209.00K | 186.00K |
| Total Other Current Liabilities | 266.00K | 103.00K | 73.00K | 209.00K | 186.00K |
| Total Current Liabilities | 15.69M | 14.19M | 16.81M | 17.27M | 31.59M |
|
|
|||||
| Total Current Liabilities | 15.69M | 14.19M | 16.81M | 17.27M | 31.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.15M | 4.67M | 5.21M | 5.74M | 6.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 19.84M | 18.86M | 22.02M | 23.01M | 37.85M |
|
|
|||||
| Common Stock & APIC | 661.57M | 631.99M | 626.63M | 479.97M | 477.18M |
| Retained Earnings | -426.20M | -400.33M | -380.13M | -359.22M | -338.93M |
| Treasury Stock & Other | -315.00K | -159.00K | 171.00K | 72.00K | -30.00K |
| Total Common Equity | 235.06M | 231.50M | 246.67M | 120.83M | 138.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 235.06M | 231.50M | 246.67M | 120.83M | 138.22M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 235.06M | 231.50M | 246.67M | 120.83M | 138.22M |
|
|
|||||